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                                                Introduction   
   The intricate anatomy of head and neck region provides 
challenge to reconstructive surgeon to restore form and function after cancer 
management. The aesthetic aspect of face has to be considered in reconstructive 
options. Surgery is the oldest treatment for cancer. Although various other 
modalities of treatment are available, surgery is the best modality in the cure of 
cancer. Also surgery helps in immediate reconstruction and rehabilitation of cancer 
patients. Both function and form have to be improved after reconstruction with 
minimal donor site morbidity. Reconstruction can be immediate or delayed. 
Immediate reconstruction is necessary for coverage of vital structures. Also it is 
easy to perform in soft pliable tissue. Delayed reconstruction is performed in 
scarred, often irradiated bed and also the tissue requirement is increased. So 
delayed reconstruction is considered only in cases of doubtful clearance of tumor, 
infection in cases of tumor necrosis, inability of patient’s condition for lengthy 
procedure. After determining the tissue defect, the reconstructive options are 
considered. The reconstructive ladder has to be considered for reconstruction. But 
in complex defect of head and neck reconstruction, for optimal function, following 
the reconstructive escalator, free flap can be used.  The other options like tissue 
expander and vacuum assisted closure can be considered where-ever possible. But 
for best form and function, multiple stages may be required in head and neck 
reconstruction. 
In head and neck reconstruction losses have to be replaced in kind. In oral cavity 
lining, cover, support has to be considered for mucosa, skin and bone loss. Like-
wise in nose lining, cover, support has to be considered for mucosa, skin and 
cartilage loss. 
 
     
 
 
 
                                       
 
 
 
 
                                              Aim of the study 
In head and neck reconstruction, multiple stages are needed to restore form, 
function and aesthetics. 
The aim of the study is to consider 
• The causative factors in head and neck malignancy. 
• Age and sex incidence of various malignancies in the head and neck region. 
• Tumor types in various sub sites of head and neck region, stage of tumor and 
management of tumor. 
• Tissue defect and options for reconstruction. 
• Complications and comorbidity in treatment outcome. 
• Secondary procedures needed for outcome. 
 
 
 
 
 
 
                                                                   Review of literature 
                                   Historical Perspective: 
1906- Crile (1)radical neck dissection 
1906- Tansini used pedicled latissimus dorsi myocutaneous flap for post 
mastectomy defects. 
1951- Edgerton (2)introduced the concept of primary reconstruction 
1963- McGregor (3) used laterally based forehead flap 
1965- Bakamjian (4) introduced the deltopectoral flap 
1976- Quillen (5) and Barton reintroduced pedicled latissimus dorsi myocutaneous 
flap 
1979- Ariyan (6) described pectoralis major myocutaneous flap 
1979- McCraw and Dibbell (7) used superior trapezius myocutaneous flap 
1980- Mathes and Nahai used inferior trapezius myocutaneous flap 
            Along with the local and regional flaps, the advent of microvascular free 
flaps forms wide armamentarium for head and neck reconstruction. 
     
                                 Goals of reconstruction 
The goals of treatment in head and neck malignancy are 
• Tumor ablation 
• Restoration of form 
• Restoration of function 
          Scope of the problem 
Head and neck cancer can have major impact on patient’s self-perception, basic 
function like speech and deglutition. Most of the cancers are preventable. Sunlight 
is the main factor in cutaneous malignancy. Alcohol and tobacco are the main 
causative factors in oral cavity carcinomas. Tobacco in any form like smoking 
(beedi, cigar, cigarettes, pipes), reverse smoking of chuttas in to oral cavity, snuff, 
chewing of pan, betel nut causes oral cavity and upper aero-digestive cancer. Other 
causes of cancer are sharp tooth, spices, poor oral hygiene, precancerous lesions, 
siderophenic dysphagia. The precancerous lesions include leukoplakia, 
erythroplakia, lichen planus, submucous fibrosis. Immunosuppression following 
transplant predisposes to skin and oral cavity cancer.     
                                       
 
                                               Surgical anatomy  
These include various sub site namely scalp, face, neck, oral cavity, pharynx and 
larynx. 
Scalp and forehead:  
Scalp and forehead are considered as a single unit with five anatomic layers 
namely skin, subcutaneous connective tissue, galea, loose areolar tissue and 
pericranium. Exception between scalp and forehead is that the scalp is usually hair 
bearing and contains a galeal layer, whereas the forehead has the frontalis muscle.  
Scalp is supplied by paired arteries in subcutaneous connective tissue layer 
traversing towards vertex with rich inter communications. The arteries are 
supratrochlear, supraorbital, superficial temporal, posterior auricular and occipital 
arteries (fig.1). Based on single dominant pedicle (example- superficial temporal 
artery) whole scalp survives because of rich inter communications. Hence in scalp 
flaps, the design of flap has to include at least one main artery for survival of flaps. 
Face: The aesthetic units of face like forehead, nose, periorbital, labial, cheek, 
auricular and temporal (fig.2) have to be considered in reconstruction with 
preservation of function. Lid and nose reconstruction needs lining, cover and 
support.  
Lid is composed of bilamellar structure between skin and conjunctiva with 
orbicularis oculi in anterior lamella; levator and muller muscle in posterior lamella; 
tarsofascial layer between lamella (fig.3). Upper and lower eyelids rest on globe. 
This relationship has to be maintained in reconstruction for blinking, corneal 
wetting and tear flow. 
Zide divided cheek into three overlapping zones: suborbital; preauricular; 
buccomandibular. Jackson classified it into five zones- lateral, lower, malar, 
superomedial, nasolabial. The cheek boundaries are lower border of mandible, 
nasal sidewall, zygomatic arch and preauricular fold. 
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Fig.3                                                           Fig.4 
Nose: 
Nose is covered by external skin, supported by a mid layer of bone and 
cartilage and lined primarily by mucoperichondrium. Aesthetically, the nose is a 
central facial feature with subunits dorsum, tip, columella, and the paired 
sidewalls, alae, and soft triangles (fig.4). Functionally, the nose must have 
unobstructed breathing.                                                                                                         
Oral cavity: 
  It extends from lip to junction of hard and soft palate superiorly; 
circumvallate papillae in tongue inferiorly and anterior tonsillar pillars laterally. 
The subsites are lip, buccal mucosa, alveolus, retromolar trigone, palate, floor of 
mouth, anterior two-third tongue (fig.5). 
                                                             Fig.5 
Lip:   
 Upper and lower lip forms separate units. Lip extends from nasal base 
superiorly to mental crease inferiorly. Laterally melolabial crease separates it from 
cheek.  Philtrum in upper lip has aesthetic significance. 
 Lip has 4 components namely mucosa, vermilion, muscle and skin. 
Vermilion is thin layer of nonkeratinized epithelium; devoid of sebaceous glands 
and hair follicles. The color of vermilion is from the underlying dense capillary 
network. 
 Orbicularis oris close the mouth. The muscles of facial expression are 
elevators (levator labii superioris alaeque nasi, levator labii superioris, zygomaticus 
major and minor, levator anguli oris and risorius); depressors (depressor labii 
inferioris, depressor anguli oris and mentalis). Neurovascular, lymphatic, and 
glandular structures mainly run between the muscular and submucosal layers. 
Upper and lower labial arteries from facial artery are the principal blood 
supply present posterior to orbicularis oris 2mm above vermilion. This knowledge 
helps in elevation of cross lip flap. 
 The lymphatic drainage of lip is to submandibular and submental 
nodes.Upper lip and lateral lower lip drain in to submandibular chain and central 
lower lip drain in to submental nodal area.  
The function of lip is facial expression, speech and food retention. 
Buccal mucosa:  
Mucosal lining from pteregomandibular raphe to lip and alveolar mucosa is 
buccal mucosa. Stenson duct opening is seen opposite second maxillary molar. 
Anterior two-third tongue:  
The oral tongue is a muscular structure with overlying nonkeratinizing 
squamous epithelium. The posterior limit of the oral tongue is the circumvallate 
papillae. Lateral aspect is the most common site of malignancy. Neck dissection 
like bilateral supra omohyoid dissection has to be done in clinically negative neck 
as occult metastasis is high (60%).  
Floor of mouth:  
Floor of mouth extends from the anterior tonsillar pillar posteriorly to the 
frenulum anteriorly and from the inner surface of the mandible to the ventral 
surface of the oral tongue. The ostia of the submaxillary and sublingual glands are 
contained in the anterior floor of mouth. The muscular floor of mouth is composed 
of the sling like genioglossus, mylohyoid and hyoglossus muscles; which serve as 
a barrier to spread of disease. Invasion into these muscles can lead to tongue hypo 
mobility and poor articulation. Neck dissection like bilateral supra omohyoid 
dissection has to be done in clinically negative neck as occult metastasis is high. 
Retro molar trigone:  
This is the tissue posterior to the posterior inferior alveolar ridge and 
ascends over the inner surface of the ramus of the mandible. This area is difficult 
to treat. 
Palate:  
It extends from inner superior alveolar ridge to hard and soft palate junction. 
It is an uncommon sub site in oral cavity malignancy. 
Alveolus:   
Mucosa covering maxilla and mandible teeth bearing area is alveolus. It is 
an uncommon sub site and the reconstruction frequently involves free bone and 
soft tissue transfer. 
Neck:  
The cervical lymph nodes draining the head and neck region are divided in to 
various levels (8).  
• Level I- submental and submandibular 
• Level II- upper deep jugular 
• Level III- middle deep jugular 
• Level IV- lower deep jugular 
• Level V- posterior triangle 
• Level VI- anterior triangle 
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The anatomical boundary for the neck node level sub sites are:
     Fig.7 
 
 
 
 
 
      Pathology  
Craniofacial skeletal tumors 
The craniofacial skeletal tumors are benign and malignant. Benign tumors 
are of developmental. Although benign tumors are common than malignant type; 
they are locally destructive. For this locally aggressive tumor like ameloblastoma, 
resection of bone is done followed by reconstruction. Malignant tumors require 
skeletal and soft tissue reconstruction. Microvascular osseo myocutaneous flaps 
are used for reconstruction. 
    Salivary gland tumors 
Most of major salivary gland tumors are benign, parotid (80%). 80% of minor 
salivary gland tumors are malignant. Malignant and recurrent benign salivary gland 
tumors need reconstruction. Facial nerve reconstruction and facial reanimation 
have to be done if nerve was removed in surgical resection. 
    Tumors of skin                              
The tumor may be non melanotic or melanoma. Non melanotic types are squamous 
cell carcinoma, basal cell carcinoma. They are ulcerative, ulcero proliferative, 
nodular. 
 
Risk factors: 
 Host: skin phenotype, syndromes, predisposing lesions, immunologic 
factors, chronic wounds and scar. 
 Environment: UV radiation- UV B, UV A; ionizing radiation; chemicals- 
arsenic, polycyclic aromatic hydrocarbons (9) 
Syndromes: Genetic disorders that reduce protection against sun exposure increase 
carcinoma risk like Xeroderma pigmentosum; gorlin syndrome (10); albinism; 
epidermodysplasia verruciformis; porokeratosis. 
Predisposing lesions:  
 Congenital: Nevus sebaceous of Jadassohn; xeroderma pigmentosum 
 Acquired: Actinic keratosis (11)(AK); Leukoplakia 
 Nevus sebaceous of Jadassohn: This congenital lesion occurs in scalp and 
face in adolescence. Well circumscribed yellowish plaque can change in-to BCC. 
 Xeroderma pigmentosum: This autosomal recessive disorder patient has 
1000 times predisposition to skin malignancy as they are incapable to repair sun 
damaged skin. 5-FU, retinoids, enzymes like T4 endonuclease V and surgical 
excision are the modalities of treatment. 
 Actinic keratosis (11): Presents as red; scaly; rough lesion. It is the 
collection of neoplastic keratinocytes at epidermis. If it extends to papillary or 
reticular dermis it is called SCC. Biopsy is diagnostic. Matrix metallo protienase 
(MMP-1) measurement predicts predisposition to SCC. There are many histologic 
variants: hypertropic, atropic, bowenoid, lichenoid. 2% or 5% topical 5-FU 
application effectively cures AK. Surgery and irradiation are other forms of 
treatment. 
 Leukoplakia (12): In Greek, it means white patch. It is present in oral or 
vulvar mucosa.  
Immune Response: 
 Natural killer cells and T lymphocytes are responsible for tumor regulation. 
Langerhan’s cell of skin present antigens to the lymphocytes. Helper T cells 
produce interferon and interleukin-2 (IL-2) to stimulate Natural killer cells. 
Tumors produce IL-10 and IL-4 to evade T cells. Sun exposed skin has altered 
immune response. Transplant recipients and HIV patients have higher incidence of 
malignancy. 
 
 
Chronic wounds and scars: 
 In 1828, Jean-Nicolas Marjolin characterized malignant degeneration of 
chronic wounds. SCC is the most common form. Although any chronic ulcer forms 
malignancy, burns scars mainly predispose to malignancy. 
Ultraviolet radiation: 
UV B causes photochemical damage to cutaneous DNA, damage to DNA repair 
mechanism and suppression of cell mediated immunity. UV A, and ionizing 
radiation are co carcinogenic to UV B. They cause mutations in tumor suppressor 
gene p53.  
Prevention: 
 Sunscreens (13), clothing, education, chemo prevention- green tea with poly 
phenolic anti-oxidants/ aloe/ retinoids/ vitamin A in actinic keratosis patients are 
all various preventive measures to reduce incidence of cutaneous malignancy. 
Basal cell carcinoma: 
BCC occurs in areas of trauma, ulcers and burns. The altered stromal cells incite 
epidermal pluripotent cells to become malignant. 
 
Tumor biology:  
                    Origin of BCC is in pluripotent cell in epithelium with cell cycle of 
217 hours (14). But the slow growth and small size is due to the fact that only the 
outer cells of tumor are dividing. BCC has predilection for growth along tissue 
planes, periosteum, nerves and embryonic fusion plane like nasolabial fold.  
  The aggressiveness of BCC (15) is due to 
  Type 4 collagenase in morpheaform BCC 
  Breached membrane continuity. 
  Reduced amyloid production. 
  Increased actin microfilaments. 
  Increased tumor fibroblast. 
Epidemiology: 
 BCC occurs in light skinned people exposed to sun light (Australians). 
Majority of cases occur in head and neck region (85%). Nose (16) is the common 
site. There is male preponderance to this tumor. 
 
 
Clinical types: 
 Superficial: (10%) The lesion is erythematous, scaly with thread like border. 
It has to be differentiated from actinitic keratosis, scc in situ, eczema and fungal 
infection. Biopsy helps in diagnosis. 
 Nodular: (50%) The lesion is nodular with telengiectatic vessel on the 
surface. It gradually enlarges; ulcerates with elevated white rolled edges and is 
called rodent ulcer.  
 Pigmented: (5%) Brown pigments due to melanin present in lesion. Blue or 
black lesion is due to intense coloring. Melanoma is the differential diagnosis.  
 Morpheaform or sclerosing: (2%) The lesion is firm plaque with ill-defined 
border with induration. It is difficult to differentiate from scar. 
 Fibroepithlioma of Pinkus: The lesion is pinkish papule like amelanotic 
melanoma. 
Histologic types (17): The subtypes are 
 Superficial-15% 
 Nodular-50% 
 Micro nodular 
 Infiltrative-15-20% 
 Morpheaform -5% 
BCC have peripheral pallisading of large basophilic cells, nuclear atypia and 
retraction from surrounding stroma. The stroma has type IV collagen with 
fibroblast. Nodular subtype has tumor cells in dermis as round mass, cyst or micro 
cyst. Micro nodule has diameter of less than 15 micro cm. The superficial type has 
basophilic buds extending from epidermis. Infiltrative type has tumor cells in 
irregular outline without pallisading as spikes. Morpheaform has collagenous 
stroma with cords of tumor cells. 
  
             Fig.8 
 
Treatment: 
 Surgical: This is by primary surgical excision or Mohs micrographic 
surgery. 
 Destructive: Electrodesiccation and curettage, cryosurgery, pulsed CO2 laser. 
 Medical: 5-FU, intralesional interferon, radiotherapy.  
Primary surgical excision:  
This is one stage treatment with primary closure or local flaps. Cure rate of 
90% (18). 5±3 mm clearance is for primary tumor and 9±5 mm for recurrent 
tumors.  
Recurrence: Tumor of less than 2 mm does not recur. 23% recurrence occurs in 
lesions of greater than 30 mm. Cystic, infiltrative and sclerosing type have high 
recurrence rate. Ear, eye have high predilection for recurrence. 
Mohs micrographic surgery: This is a tissue sparing surgery. 
 1936- Fredrick Mohs (19)- chemo surgery: 20% zinc chloride is applied to 
tumor and tissue fixation in situ was done. Excision of tumor and horizontal 
section made for frozen section examination. It is time consuming; laborious; zinc 
chloride paste application is painful; inflammatory response obscures histological 
examination; inflammation needs delayed repair. 
 1970- Theodore Tromovitch and Samuel Stegmen- popularized fresh tissue 
technique. Under local anesthesia, initial curettage of lesion is done followed by 
mapping of size and shape done. Tangential excision of tumor with minimal 
normal margin excised and mapped. Horizontal frozen section from deep and 
peripheral margins mark tumor tissue. These areas are further excised, mapped, 
examined. 
The advantages are tissue preservation, high cure rates and low morbidity.  
The indications are  
• Primary tumors at ear, eye, nose, paranasal region with high recurrence rates 
• Tumor with ill defined border or arising from scar 
• Tumors with high incidence of recurrence like morpheaform, microcystic 
adnexal carcinoma and dermato fibro sarcoma protuberans.    
• Signs of aggressiveness 
• Large tumors 
•  SCC with peineural invasion 
• Eye lids where tissue preservation is essential 
• Recurrent tumors 
Electrodesiccation and curettage: This is indicated for only small tumors and 
superficial tumors. 
Cryosurgery: Zacrian formulated guidelines for cryosurgery. The indications for 
cryosurgery are nodular ca, tumors with well defined borders, tumors over bone or 
cartilage, tumors over nose or eye lid, recurrent tumors after radiotherapy, lentigo 
maligna, elderly patients and palliative. The contraindications are cold intolerance, 
morpheaform or sclerosing BCC, eyelid margin, lip vermilion and large tumors. 
The complications are edema, pigment loss and long period of morbidity.  
Pulsed CO2 Laser: High energy short pulsed CO2 laser is indicated in superficial 
BCC (3 passes on tumor and 4mm of surrounding skin). Laser is not useful in deep 
tumors.  
Medical treatment: 5-FU is indicated in premalignant lesion like actinic keratosis. 
Radiotherapy is reserved for high risk elderly patients. Alfa-2 interferons are used 
to treat BCC, melanoma, condyloma, cutaneous lymphoma and kaposi’s sarcoma. 
 Second tumors: The estimated risk is 35% at 3 years and 50% at 5 years. It is 
of same histological type as first tumor.  
 Metastatic tumors: Metastatic BCC incidence is less than 0.1% to lymph 
node, lungs and bones. Metastasis is by both lymphatic and hematogenous spread. 
     
 
                                  Squamous cell carcinoma  
Squamous cell carcinoma may arise from normal skin or from premalignant lesions 
like actinic keratosis, scar and leukoplakia. They may be present as ulcer, ulcero 
proliferative, nodular, verrucous or papillomatous type. The in-situ lesion is called 
Bowen’s disease. 
Tumor biology: 
 SCC arises from basal layer of epidermis and mucous membrane with cell 
cycle of 50.2 hours (20)and hence faster growth of tumor.  
Histology: 
 Histology shows irregular mass of squamous cells proliferating downwards 
to dermis with varying degree of differentiation(fig.9). Size, shape, 
hyperchromasia, kertinization, mitotic figures determines tumor grade. In 1921 
Broders proposed 1-4 grades with >75%, >50%, >25%, <25% of differentiated 
cells. Undifferentiated tumors must be analyzed by immunohistochemical assays. 
Perineural invasion in histology predicts eight fold increase of SCC metastasis.  
 Fig.9 
Treatment: 
 Wide local excision with precise margin control is the treatment of choice. 
Tumor of less than 2 cm can have 4 mm clearance. Tumor of> 2cm needs 1cm 
clearance. 
Metastasis:  
 Head and neck SCC has 10-20% risk of lymph node metastasis. Patient with 
lymph node metastasis need multimodality treatment like regional 
lymphadenectomy, wide local excision, radiotherapy and systemic chemotherapy. 
Recurrence:  Recurrence of SCC depends on tumor grade, depth of tumor invasion, 
perineural invasion by tumor. 
SCC variants (21): 
 Marjolin ulcer: Aurelius Cornelius Celsus- first described SCC in old burn 
scar. In 1827- Marjolin described tumor from chronic wounds.  
 Verrucous carcinoma: Occurs without predisposing cause or precancerous 
lesion as exophytic growth in oral mucosa of older individuals. It is radio-resistant. 
Surgical management is the cure and recurrence at different site as second or third 
primary is common. 
Malignant melanoma: 
  Malignant melanoma arises from the melanocyte cell of skin. The 
American Cancer Society ABCD guidelines for diagnosis are  
A- asymmetry 
B- border irregularity 
C- color change 
D- increase in diameter 
The types of melanoma are superficial spreading, nodular, lentigo maligna, acral 
lentiginous, amelanotic melanoma. TNM classification stages the tumor. Breslow 
thickness and Clarke’s invasion are prognostic factors. Surgery with elective 
lymph node dissection is the treatment of choice. 
Other skin malignancies: 
 Adnexal carcinomas- merkel cell carcinoma, meibomian gland carcinoma, 
eccrine carcinoma, dermatofibrosarcoma protuberans, Kaposi sarcoma,cutaneous T 
cell lymphoma  
                               Diagnosis  
• Biopsy- edge wedge biopsy 
• Fine needle aspiration cytology of lymph node- aspiration after clinical 
palpation or ultrasound / CT guided can be done 
• Computed tomography (CT) (22)- best choice for evaluating bony 
involvement. Mandible involvement can be diagnosed clinically; x ray; 
panorex; bone scan; CT scan. In CT two patterns can be found- erosive due 
to pressure with bone destruction defect of sloping edge; invasive with 
irregular defect. 
 Lymph node metastasis can be diagnosed with 91% accuracy by clinical 
and CT evaluation. Lymph node involvement is diagnosed by round rather than 
oval node of greater than 1cm diameter, extracapsular spread, 3 or more 
contiguous node of 8-15 mm and node with central necrosis 
• Magnetic resonance imaging (MRI)  is useful for better soft tissue 
delineation in difficult areas. 
• Positron-emission tomography- the radionuclide (F-18) fluorodeoxyglucose 
(FDG) is taken-up by rapidly dividing cells. It is useful in follow-up after 
surgery or radiotherapy to detect local recurrence. 
• Triple endoscopy- for diagnosing synchronous lesion, bronchoscopy; 
pharyngoscopy; upper GI scopy has to be done especially in high risk 
patients and symptomatic patients. 
Staging  
 On the basis of TNM classification, clinical stage of tumor can be 
determined. T for tumor; N for nodal status; M for metastasis determines the stage. 
Staging aids in treatment planning, choice of therapy and prognosis estimation. N, 
M stage is the same in head and neck malignancy whereas T stage differs 
according to sub site. 
Tumor stage of oral cavity: 
 T1: Tumor size less than 2 cm 
 T2: Tumor size 2-4 cm 
 T3: Tumor size larger than 4 cm 
 T4: Tumor invasion of adjacent tissues. 
Nodal stage: 
 N0: No node 
 N1: Ipsilateral single node of up to 3 cm 
 N2a: Ipsilateral single node of 3-6 cm 
 N2b: Ipsilateral multiple nodes of up to 6 cm 
 N2c: Bilateral nodes of up to 6 cm 
 N3: node of greater than 6 cm 
Metastasis stage: 
 M0: No metastasis 
 M1: Distant metastasis 
Stage group: 
 0: TIS, N0, M0 
 I: T1, N0, M0 
II: T2, N0, M0 
III:  T3, N0, M0; T2, N1, M0; T1, N1, M0; T3, N1, M0 
IV:  T4, N0, M0; T4, N1, M0; Any T, N2, N3, M0; Any T, any N, M1 
Neck management: 
  The traditional radical neck dissection involves removal of level I-V 
nodes, spinal accessory nerve, internal jugular vein and sternocleidomastoid 
muscle. Modified radical neck dissection spares one or more of muscle, nerve, vein 
to reduce morbidity. Selective neck dissections have been done to limit morbidity 
and to target occult metastasis.  
N0 neck – supra omohyoid neck dissection. 
N+ neck – N1 - supra omohyoid neck dissection. 
  N2,3 – modified radical neck dissection / supra omohyoid neck 
dissection.+ radiotherapy .     
                                          Reconstruction  
The various modalities for head and neck reconstruction are from primary suturing 
to free flap. After considering the defect, to achieve form and function the 
reconstructive option is selected. 
 
Primary closure:  
It is possible to close the defect primarily after tumor resection by surgery or 
Mohs micrographic surgery in small tumors with adjacent loose tissues.  
Skin graft:  
Full thickness graft has good aesthetic cover in face although restricted by 
reduced take and limited donor size. Inlay graft can be used in buccal mucosal 
defect. Although aesthetically poor, recurrence can be easily detected. 
Local flaps: 
The design depends on available lax local tissue. The sites of laxity are 
glabella, temple, nasolabial, mandibulomasseteric area. The plane of elevation is 
above facial muscles in sub dermal layer in face; sub platysmal in neck; sub 
frontalis in forehead; sub galeal in scalp. The aesthetics of facial sub unit has to be 
considered in reconstruction of face. 
The flaps are of two types: flaps that rotate about a pivot point (rotation, 
transposition, island and interpolation flaps) and advancement flaps (single-pedicle 
advancement, V-Y advancement, Y-V advancement, and bipedicle advancement 
flaps). 
  
Fig.10 
 
Fig.11                                                       Fig.12 
In head and neck reconstruction, local flap without donor morbidity is selected for 
aesthetic considerations. 
Regional flap: 
The flaps useful in head and neck reconstruction are forehead flap and pectoralis 
major myocutaneous flap. 
 
Forehead flap: 
McGregor described a flap based on the superficial temporal vessels. The flap was 
folded and tunneled through the cheek to enter the oral cavity just below the level 
of the zygomatic arch; at a second stage the pedicle was divided and  
Pectoralis major (23) and deltopectoral flap: 
Type V muscle supplied by thorocoacromial artery. DP flap has dominant blood 
supply from intercostals perforators. 
A line drawn between the acromion and the xiphoid and perpendicular line 
drawn from midclavicular point to reach the line marks the axis of the pedicle of 
the flap. DP flap based on II, III and IV perforators is raised. Skin paddle marked 
and lower border incised including rectus. Cutaneous paddle islanded along with 
muscle except proximally preserving the pedicle.  
On either side of pedicle, musculocutaneous flap raised to reach the donor site in 
head and neck region. This flap is easy to harvest and is the work-horse flap for 
head and neck reconstruction. 
FREE FLAP: 
In head and neck reconstruction, the preferred free flaps are radial forearm flap, 
scapular, parascapular, ALT and vascularised fibula flap. Of which RFF is the best 
option for head and neck reconstruction. 
Free radial forearm flap: 
• It is a type B fasciocutaneous flap harvested from the forearm of the non-
dominant hand based on the radial artery and the venae commitantes or the 
cephalic vein 
• First described by yang et al in 1981 from China 
Anatomy: 
• Radial artery arises from the brachial artery 2-2.5 cm. below the cubital 
fossa. 
• The artery lies in the lateral intermuscular septum between the 
Brachioradialis and FCR. 
• Proximal 2/3rd is deep between the muscle bellies of Brachioradialis and 
FCR and the distal 1/3rd is superficial lying between their tendons 
 
Fig.13 
• Radial artery gives 9-17 septocutaneous perforators. 
• The periosteal supply to the radius is provided by the attachment of the 
lateral intermuscular septum to the radius. 
• Two system of veins 
• Superficial- Cephalic (diameter- 2.5mm)and Basilic veins 
• Deep – Venae commitantes (diameter1.5mm) of radial artery. 
• Can be harvested as sensate flap (24) by including medial or lateral 
cutaneous nerve of forearm. 
Advantages: Has thin pliable skin. Used in head and neck reconstruction. 
Contraindications: Allen’s test positive / equivocal, chemotherapy infusion on that 
hand/ forearm, major injury/ # at the forearm. 
Surgical technique: Radial artery course is marked from cubital fossa to radial 
styloid. Vein is also marked. Flap according to defect is marked with distal margin 
3cm proximal to wrist; ulnarly over FCU; laterally and proximally according to 
defect. With proximal incision cephalic vein dissected up to cubital fossa and distal 
and radial incision made .Distally vein and radial artery ligated. Subfascial 
elevation of flap done along with artery and vein. Pedicle harvested according to 
requirement. 
                      
                        SUBSITE RECONSTRUCTION 
Scalp reconstruction:  
The defect size determines the reconstructive options available. 
Less than 3 cm: The options available are  
• Primary closure 
• Skin graft 
• Scalp flap ± galeal scoring: galeal incisions of 1-2 cm apart are made 
• Pericranial and galeal flap + SSG 
Defect of 3-6 cm: Rotation flap ± galeal scoring 
Defect of 6-9 cm:  
• Transposition flap with SSG for donor area 
• Pedicled flap 
• Free flap 
Defect greater than 9 cm (25): Free flaps 
 The free flaps useful in scalp reconstruction are LD, rectus abdominis, 
serratus anterior, ALT, omental flap. The recipient artery is superficial temporal 
artery and to reach vein in neck interpolation vein graft may be needed. VAC and 
tissue expanders are used in appropriate places. 
Forehead reconstruction:  
Primary closure if possible has to be done.  
Lateral defect are closed easily than the central defect. 
For defect up to 40% local flaps preserving hair line are used.  
For larger defect free RFF or groin flap is ideal.  
Tissue expander is a reconstructive option to be considered. 
Eye lid reconstruction:  
The primary goal is protection of cornea for vision and secondary goal is aesthesis. 
The principles of reconstruction (26)are 
• Evaluation of the defect and function of the lid. 
• Components of defect- identified and documented. 
• Preoperative ophthalmologic examination. 
• Aesthetic attention in eyelid 
• When approximating lid margins, alignment of all layers must be achieved. 
• Suture material- avoid direct contact with the surface of the cornea  
• Reconstructive ladder in reconstructive options 
• Non keratinising mucosal epithelium for lining. 
• Apposition of lid to globe for tear film movement. 
• Upper lid protects cornea and mobility of it essential. Supple thin skin for 
upper id excursion. Lower lid has dam effect preventing epiphora. 
Upper eyelid (27): 
Defect up to 25% can be sutured primarily with or without canthotomy. 
Defect of 25%-75% -flaps like cutlerbeard and hughes are used 
Defect greater than 75%- lid switch with cheek advancement flap 
Lower eyelid: 
Defect up to 50%- primary closure with or without canthotomy; Hughes flap. 
Defect of 50%-75% - Hughes flap. 
Defect of > 75%- cheek flap with nasal or palatal mucosa for lining. 
Other flaps like glabellar flap, forehead flap, nasolabial flap, island postauricular 
flap and free first web space flap of foot can be used. 
Nose reconstruction: Reconstruction has to restore lining, cover and cartilaginous 
support. Breathing must be unobstructed. Missing tissues must be replaced in the 
exact amount. If too little is replaced, adjacent landmarks will be distorted, 
collapsing underlying cartilage grafts. If too much is resupplied, adjacent 
landmarks will be pushed outward, distorting the external shape or pushing the 
lining inward, obstructing the airway. 
General Principles of Reconstruction (28): 
• Reestablishment of normal appearance and three-dimensional contour. 
• Tissues for cover, lining, and support are planned. 
• Resurfacing the entire subunit if > 50% of that unit is involved. 
• A template of the contralateral normal side is made to create a mirror image 
of the true defect or subunit. 
• Avoid overfilling or underfilling of the defect. 
• Choose ideal donor materials for skin, support and lining. 
• Ensure a stable platform. 
• Composite defects are usually reconstructed in stages. The lip and cheek are 
repaired before the nose. 
  For lining, hinge flap; prelamination of graft; intranasal mucosa; skin graft; 
forehead flap are the options. Auricular and septal cartilage provides nasal support.  
 
   
Fig.14                                           Fig.15 
The cover defect (29) may be small (up to 1.5 cm) or large (> 1.5 cm). Small 
defect can be covered by banner flap, bilobed flap, nasolabial flap. For the large 
defects nasolabial and forehead flaps are used. The site and size of defect 
determines reconstructive options. 
 
Cheek reconstruction: 
The defect may be simple involving skin and subcutaneous tissue or complex 
requiring lining, cover, facial nerve reconstruction. Suborbital; preauricular 
reconstruction can be done by local flaps. Buccomandibular region reconstruction 
needs regional or free flap. The options available are primary closure, skin graft, 
local flaps and regional flaps. Tissue expansion and free flaps are other options. 
The algorithm for cheek reconstruction (30): 
 Oral cavity reconstruction: 
Reconstruction the oral cavity is a difficult challenge for the plastic surgeon 
because of the variety of anatomic structures and complexity of functions involved. 
The goal is restore form and function. 
The oral sphincter participates in mastication, speech, and deglutition. It 
provides a watertight closure during the preparation of the bolus and prevents the 
escape of saliva. The alveolar ridges directing the flow of saliva and collecting the 
food during the bolus process. The floor of the mouth is important to allow 
unrestricted mobility of the oral tongue. The buccal mucosa lines the cheek and is 
important for mastication and deglutition. 
Lip reconstruction:  
Lip is the primary aesthetic feature of the lower central face. 
Four basic components in reconstruction are: 
–  the skin and subcutaneous tissue, 
–  the muscle,  
– the mucosa, and 
–  the vermilion  
The functions of lips are oral competence, articulation, deglutition and 
expression of emotion. The essentials of lip reconstruction are skin cover, lining, 
stomal diameter, vermilion, oral sphincter competence. 
Vermilion reconstruction (31): The options are  
• Mucosal advancement flap 
• Interpolated cross lip vermilion flap 
• Mucosal cross lip flap 
• Tongue flap 
For lip reconstruction the following options are available depending on site of 
defect and amount of loss. 
• Primary repair: up to one third loss. 
• Advancement flap: For central defect- rectangular or step ladder flap 
(fig.16), Bandoneon flap 
• Rotation advancement(fig.17): For lateral defects- gilles, McGregor, 
Nakajima, Karapandzic neuro-vascular flap 
• Cross lip: For two-third loss-Abbe flap lower lip to upper lip for central and 
lateral defect; estlander flap (fig.18)for lateral defect 
• Pedicled flap: defect > than two-third and in total lip defect- forehead; 
temporoparietal scalp flap like single pedicled or bucket handled; 
deltopectoral flap 
• Free flap: RFF 
fig.16 
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Lip reconstruction can be done with local tissue for up to half to two third loss 
after which distant flap or free flap are used. 
Buccal mucosa:  
The radial forearm flap is ideal for buccal defects. Forehead flap and PMMC 
are pedicled flaps used in reconstruction.  
Tongue:  
Most difficult structure of the oral cavity to reconstruct. Tongue 
reconstruction has to restore speech and swallowing. The radial forearm free flap is 
an ideal choice, if 20% to 30% of the muscle is present for maintenance of some 
function.  
The rectus abdominis myocutaneous flap, the anterior lateral thigh (32), and 
the scapula/parascapular flap are preferred in glossectomies to add bulk and for 
deglutition if remnant tongue is less than 20%.   
Floor of mouth:  
Reconstruction must allow for free mobility of the oral tongue. The 
nasolabial flap (33) based on the angular artery can be used for defects of the 
anterior floor of mouth. Forehead flap, the facial artery musculomucosal flap 
(FAMM), and the deltopectoral flap are other options. 
Free tissue transfer is preferred. The sensate radial forearm flap through 
neurorrhaphy of the medial or lateral cutaneous nerve to the lingual or other 
sensory nerves in the neck is the best choice. The anterolateral thigh, the 
temporalis fascial flap are other options. 
Mandible reconstruction: 
Mandible is necessary for airway stability, speech, deglutition, and 
mastication. Aesthetically it is the main component for shape of the lower face. 
Functional goals to be obtained are maximal opening and maintenance of 
occlusion. Aesthetic goals include symmetry, preservation of lower facial height, 
anterior chin projection, and correction of submandibular soft-tissue neck defects. 
Classification: Bone loss in terms of central segments (designated C and 
defined as lying between the two canine teeth), lateral segments (L), and 
hemimandible segments (H).  
Mandible reconstruction options are nonvascularized bone grafts, metal 
plates, pedicled flaps (34), prosthesis and free flaps. Nonvascularized grafts, like 
iliac crest, can be used for a short bone gap (<3 cm). Pedicled flaps include the 
trapezius and pectoralis osteomyocutaneous flaps. The bone available is limited. 
Prosthetic mandible has high chance of extrusion. Metal reconstruction plates 
although don’t use donor bone, risk of exposure; infection; risk of plate fracture; 
preclusion of dental reconstruction and reduced bulk are the disadvantages. 
 The free vascularised bone flap donor sites include ilium, radius, scapula and 
fibula. Fibula is the best choice as already described. 
           
  
                                  
 
 
 
                               
 
 
 
 
                               MATERIALS AND METHODS 
MATERIALS: 
  The study includes the study of 58 patients who underwent 
reconstruction for Head and Neck Malignancies at the Department of Plastic 
surgery, Government Rajaji Hospital, Madurai. The study was from August 2010 
to February 2013. 
METHODS: 
  The methods include obtaining history from patients, thorough 
clinical examination and necessary investigations and appropriate surgical 
reconstruction.  
  An informed written consent was obtained from every patient to 
include in the study. Proper preoperative counseling regarding the nature of the 
disease, treatment plan, complications and follow-up was done. 
  All information was entered in a proforma specially designed 
for this study. 
METHODOLOGY: 
  The patient’s name, age, sex, history of presenting illness and 
its duration was obtained. Past history of chronic medical illness and previous 
surgical history noted. Associated co-morbid conditions noted. Personal history 
like smoking, alcohol consumption, betel nut chewing and diet pattern were 
obtained. 
  Detailed physical examination of the tumor, nodal status, 
metastatic status and donor site evaluation was done. 
  Basic investigations like blood haemoglobin estimation, urine 
examination, blood sugar, blood group and renal parameters like urea, creatine 
were done. X-ray chest was obtained for anesthetic purpose and metastasis work-
up. Cardiac evaluation regarding fitness for surgery obtained. 
 
 
 
 
 
 
 
 
                            OBSERVATION AND RESULTS: 
  
Table-I
Age incidence
S.No Age No %
1 UP TO 40 yrs 2 4
2 41-50 11 19
3 51-60 26 45
4 61-70 17 29
5 >70 2 3
Total 58
Range 30-80 yrs
Mean 58 yrs
SD 8.96
 
The age incidence in skin and oral cavity malignancy are: 
Table-II Age incidence in 
skin tumors
S.No Age No %
1
41-50 1
7
2
51-60 9
64
3
61-70 3
22
4
>70 1
7
Table-III Age incidence in  
oral cavity malignancy
S.No Age No %
1 UP TO 
40 yrs 2
5
2 41-50 8 20
3 51-60 16 39
4 61-70 14 34
5 >70 1 2
 
 The sex incidence of head and neck malignancy are: 
Table-IV
Sex incidence 
S. no Sex No %
1 Male 25 42%
2 Female 33 58%
The sex incidence in cutaneous BCC and oral cavity SCC are as follows:
Table- V
Cutaneous BCC  
Sex incidence
S. no Sex No %
1 Male 4 36%
2 Female 7 64%
Table-VI
Oral cavity SCC 
Sex incidence
S. no Sex No %
1 Male 19 49%
2 Female 20 51%
 
 The tumor types in head and neck malignancy and in subsite are:  
TABLE-VII
TUMOR TYPE
S.NO SITE TUMOR NO
1 SKIN BCC 11
SCC 02
OTHERS 01
2 ORAL CAVITY BCC 0
SCC 39
OTHERS 02
3 NECK BCC 0
SCC 1
OTHERS 2
TOTAL 58
TABLE VIII-TUMOR IN SUBSITE
BCC SCC OTHERS TOTAL
SKIN
FOREHEAD 2 0 0
14
SCALP 0 2 0
NOSE 3 0 0
CHEEK 5 0 0
TEMPORAL 0 0 1
PERIORBITAL 1 0 0
ORAL                     
CAVITY
BUCCAL 0 24 0
41
LIP 0 11 1
TONGUE 0 2 0
FLOOR 0 1 0
ALVEOLUS 0 0 1
PALATE 0 1 0
NECK 0 1 2 3 
TOTAL 58
 
The tumor subsite incidence in cutaneous BCC and oral cavity SCC are: 
              
                TABLE- IX CUTANEOUS BCC INCIDENCE 
SUBSITE CHEEK NOSE FOREHEAD PERIORBIT 
% 46 27 18 9 
 
                  
                        TABLE- X ORAL CAVITY SCC INCIDENCE 
SUBSITE LIP BUCCAL TONGUE FLOOR PALATE 
% 28 61 5 3 3 
 
 
                       TABLE- XI LIP MALIGNANCY INCIDENCE 
LIP UPPER LIP LOWER LIP 
NO & % 2 & 17% 10 & 83% 
 
 
The management of neck and mandible in head and neck malignancy is:
TABLE-XII NECK MANAGEMENT
S.NO TYPE NO
1 RADICAL 6
2 SELECTIVE 14
3 NO SURGERY 38
TOTAL 58
 
TABLE-XIII MANDIBLE MANAGEMENT 
IN 
ORAL CAVITY MALIGNANCY
MANDIBLE DEFECT NO MANAGEMENT NO
HEMIMANDIBULECTOMY 8
RECONSRUCTION PLATE 0
MICROVASCULAR 0
CENTRAL SEGMENT 1
MICROVASCULAR 0
FREE BONE 0
RECONSRUCTION PLATE 1
LATERAL SEGMENT 4
MICROVASCULAR 0
FREE BONE 0
RECONSRUCTION PLATE 3
 
 
     TABLE- XIV Reconstruction in skin malignancy 
Reconstructive options No & % 
Local(primary suturing, SSG, flaps) 8 & 57% 
Distant  6 & 43% 
 
TABLE- XV RECONSTRUCTION IN ORAL CAVITY MALIGNANCY 
 FOREHEAD PMMC RFF OTHERS 
BUCCAL 20 2 1 1 
LIP 9 0 0 3 
TONGUE 0 2 0 0 
FLOOR 0 0 0 1 
ALVEOLUS 1 0 0 0 
PALATE 1 0 0 0 
 
 
                                             
 
 
                                          Discussion: 
  Ω The head and neck malignancy occurs mainly in sixth or seventh 
decade. BCC occurs mainly in head and neck region with 86% incidence in age 
range of 40-79 years (35). Oral cavity malignancy occurs mainly in sixth or 
seventh decade. 
  In our study head and neck malignancy occurs in age range of 30-80 
years with mean age incidence of 58 years and standard deviance of 8.96. 
Cutaneous malignancy has 64% incidence in 51-60 age groups and oral cavity 
malignancy has 39%; 34% age incidence in 51-60; 61-70 age groups respectively. 
 Ω Head and neck malignancy has higher incidence in male with male: 
female ratio of 4:1(35). Contrarily, in our study there is increase in female incidence 
of head and neck malignancy. Oral cavity malignancy has equal sex incidence and 
Cutaneous BCC has increase in female sex incidence. The sunlight exposure and 
non-usage of preventive measures like sunscreens contributes to the increased 
incidence. 
Ω In skin, BCC is the common type and in the oral cavity SCC is the 
common type of malignancy in head and neck. In cutaneous malignancy, SCC 
forms only one-fourth the incidence of BCC. In cutaneous BCC, nose (26%) is the 
most common site followed by cheek (18%) (16). 
In our study Cutaneous BCC and oral cavity SCC is the most common 
presentation. In Cutaneous BCC, cheek (46%) has higher incidence followed by 
nose (27%). 
Ω In oral cavity SCC, the sub site incidence is as follows: 
• Tongue- 37% 
• Lip- 25-30% 
• Floor of mouth- 10-15% 
• Buccal mucosa- 5% 
• Palate- 0-5% 
In our study buccal mucosa (61%) followed by lip (28%) is the incidence in oral 
cavity malignancy. The use of smokeless tobacco with betel nut, in pan (36) is the 
main predisposing factor in increased incidence of buccal mucosa carcinoma.  
Ω Lower lip (37) is the most common site (>90%) in lip malignancy with > 
90% being SCC. 
83% of lip malignancy is in lower lip and 92% of lip malignancy is of SCC.   
Ω The other types of skin malignancy are SCC and merkel cell carcinoma. 
In oral cavity, one case presents as mucosal melanoma. The neck tumors presented 
for reconstruction are nodal secondary, recurrent thyroid carcinoma and salivary 
gland malignancy. 
Ω For Cutaneous malignancy, Mohs micrographic surgery (38) is the best 
modality of treatment with 99% cure rate for BCC and 95% cure rate for SCC. 
Surgery is the next best method with cure rate of 95% for both BCC and SCC. For 
BCC 4mm margin clearance is required. For Cutaneous SCC, surgical 
management is as follows: 
 
 
 
 
In our cases for BCC 0.5 cm clearance and 2 cm clearance for SCC was given. 
Ω For oral cavity malignancy, margin of 1-1.5 cm is recommended. We 
have 2cm clearance for oral cavity malignancy. 
Ω In cutaneous malignancy, lymph node metastasis has poor prognosis. In 
metastatic cutaneous malignancy, lymph node dissection along with radiotherapy 
and chemotherapy must be given. Merkel cell carcinoma is an aggressive 
Tumor of < 
2 cm 
4 mm 
margin 
Tumor of > 2 
cm diameter 
1 cm 
margin 
cutaneous malignancy which along with 3-5 cm margin clearance needs elective 
neck dissection. 
In our study, all cutaneous malignancy patients had N0 neck. Merkel cell 
carcinoma patient underwent modified radical neck dissection. Other patients do 
not need any form of treatment to neck.  
     Ω In oral cavity malignancy, N0 neck patients can be treated with neck 
dissection or radiotherapy. N+ neck patients are treated with modified radical neck 
dissection ± radiotherapy (8).   
In our study, 4 oral cavity malignancy patients had modified radical neck 
dissection and 14 patients had selective neck dissection. The remaining 23 patients 
do not have primary neck dissection.   
Ω For mandible reconstruction, vascularised fibula is the best option for 
both form and function. 13 patients underwent mandibular resection but only 3 
patients had mandibular reconstruction plate. None had bone graft. 
The hemi mandibulectomy patient, without mandible reconstruction, had 
contour deficit, deviation, comissure cant. Although their mouth opening is 
adequate with only slight restriction. Reconstruction plate patients have loss of 
bulk but cotour maintained. 
Ω In cutaneous malignancy, local flaps give better aesthetic outcome. The 
complex defect like eyelid, nose and merkel cell carcinoma had distant flap. 
The options for cutaneous malignancy reconstruction are 
 
 
 
 
                     
 
Primary closure is possible if surrounding tissue is lax. FTSG can be used in head 
and neck defect. 
In oral cavity malignancy, free flap provides one stage reconstruction for the 
complex defect. Regional flaps like forehead flap and PMMC flap can also be 
used. Forehead flap has donor site morbidity while PMMC may be bulky. This is a 
viable alternative in situation of case load, prolonged operative time in learning 
curve period for free flap. 
  Ω The complications noted are 
Defect of < 
2cm 
Defect of > 
2cm 
Complex defect 
like eyelid, nose 
Primary 
closure 
Local flap 
Local flap 
Distant flap 
Distant flap + 
support 
Free flap 
• Immediate- dehiscence, partial or total flap loss. 
• Late- recurrence 
There is dehiscence in two cases. There is cachexia in one case. 
Partial flap loss is present in two cases. There is DM in one case. 
Total flap loss is present in three cases. There is HT in one case and one patient is 
cachectic. 
There is recurrence in three cases. One is BCC and others are oral cavity SCC.  
Ω Secondary procedures like flap thinning done in two cases. Only two 
cases underwent comissuroplasty.  
 
 
                                     
 
 
 
 
                                         Conclusion: 
• Mean age incidence of head and neck malignancy is 58 years with standard 
deviation of 8.96. 
• Cutaneous BCC has higher female sex incidence and oral cavity malignancy 
has equal sex incidence. 
• In head and neck malignancy, BCC is the most common skin tumor and 
SCC is the most common oral cavity malignancy. 
• Cheek is the most common sub site of cutaneous BCC followed by nose and 
buccal mucosa is the most common oral cavity sub site followed by lip. 
• The margin of clearance is 0.5 cm for BCC and 2cm for SCC. 
• Except for merkel cell carcinoma patient, other cutaneous malignancy 
patients do not need any form of treatment to neck.  
• In oral cavity malignancy, N0 stage patient without neck dissection have to 
be followed up and radiotherapy to be given to the neck. 
• Mandible reconstruction with vascularised fibula gives good aesthetic result. 
• Local flaps provide aesthetic cover for cutaneous malignancy. 
• Although free flap is ideal for oral cavity malignancy, regional flaps are 
viable alternative. 
• Comorbidity factors like diabetes mellitus and hypertension control reduce 
complication rate. 
• Secondary procedures like flap thinning, comissuroplasty improves the 
functional and aesthetic outcome.  
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